For research use only. Not for therapeutic Use.
Salazopyridazine is an antibacterial agent. Salazopyridazine shows activities against ulcerative colitis. Salazopyridazine can be used for the research of rheumatic diseases[1][2].
| Catalog Number | I042923 |
| CAS Number | 22933-72-8 |
| Synonyms | 2-hydroxy-5-[[4-[(6-methoxypyridazin-3-yl)sulfamoyl]phenyl]diazenyl]benzoic acid |
| Molecular Formula | C18H15N5O6S |
| Purity | ≥95% |
| InChI | InChI=1S/C18H15N5O6S/c1-29-17-9-8-16(21-22-17)23-30(27,28)13-5-2-11(3-6-13)19-20-12-4-7-15(24)14(10-12)18(25)26/h2-10,24H,1H3,(H,21,23)(H,25,26) |
| InChIKey | YFUATOCFMCWUEH-UHFFFAOYSA-N |
| SMILES | COC1=NN=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O |
| Reference | [1]. Sigidin IaA. Institut Revmatizma RAMN i progress antirevmaticheskoĭ terapii [Institute of Rheumatology and progress of antirheumatic therapy]. Vestn Ross Akad Med Nauk. 1998;(12):7-9. [2]. Belohlavek D, et al. Entzündliche Darmerkrankungen Colitis ulcerose und M. Crohn. Frühdiagnose und Behandlung [Inflammatory intestinal diseases: ulcerative colitis and Crohn’s disease. Early diagnosis and treatment]. Fortschr Med. 1976 Mar 4;94(7):358-62. |
